The recent Scientific Committee on Health, Environmental and Emerging Risks Final Opinion on "The need for nonhuman primates in biomedical research, production and testing of products and devices" (2017 SCHEER) highlights approaches that could significantly contribute to the replacement, reduction, and refinement of nonhuman primate (NHP) studies. Initiatives that have the potential to affect NHP welfare and/or their use are expected to be appropriate, fair, and objective and publicly disseminated information focused on NHPs in biomedical research, which includes toxicologic and pathologic research and testing, should be objectively evaluated by stakeholder scientists, researchers, and veterinarians. Thus, IQ Consortium member companies convened to develop an informed and objective response, focusing on identifying areas of agreement, potential gaps, or missing information in 2017 SCHEER. Overall, the authors agree that many positions in the 2017 SCHEER Opinion generally align with industry views on the use of NHPs in research and testing, including the ongoing need of NHPs in many areas of research. From the perspective of the IQ Consortium, there are several topics in the 2017 SCHEER that merit additional comment, attention, or research, as well as consideration in future opinions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0192623319857976 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Limitations of Estimating BIA-ALCL Incidence Risk Using Implant Sales Data and the Italian National Breast Implant Registry.
Aesthetic Plast Surg
December 2024
Department of Neuroscience, Mental Health and Sense Organs (NESMOS), Chair of Plastic Surgery, Azienda Ospedaliera Sant'Andrea, UOD of Plastic Surgery, Sapienza University of Rome, Faculty of Medicine and Psychology, Via di Grottarossa 1035-1039, 00189, Rome, Italy.
Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.
View Article and Find Full Text PDFThe consequences of the new European reclassification of non-invasive brain stimulation devices and the medical device regulations pose an existential threat to research and treatment: An invited opinion paper.
Clin Neurophysiol
July 2024
Department of Head and Skin - Psychiatry and Medical Psychology, Ghent Experimental Psychiatry (GHEP) Lab, Ghent University, Ghent, Belgium; Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Psychiatry, Brussels, Belgium; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
Article Synopsis
- - A lot of neuroscience research in Europe uses methods like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), which are important for studying brain function.
- - New EU regulations, particularly the Medical Device Regulation (MDR), have created confusion and problems in the non-invasive brain stimulation field, as they categorize some non-medical NIBS products with high-risk invasive devices.
- - To address the negative impact of overregulation on research and innovation, a diverse group of stakeholders, including researchers and ethicists, has come together to promote discussions aimed at improving regulatory practices.
Article Synopsis
- There is a lack of high-quality evidence regarding breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), prompting the need for multidisciplinary consensus guidelines for its diagnosis and management, particularly linked to textured implants.
- An expert consensus conference evaluated existing literature by conducting a thorough search of medical databases, resulting in 145 articles being analyzed for insights on BIA-ALCL, including its incidence, risk factors, and treatment options.
- Recommendations emphasize the importance of tailored patient surveillance based on implant type, highlighting the necessity of ongoing research for better understanding and prevention of BIA-ALCL in patients.
Engagement with emotional concerns in general practice: a thematic analysis of GP consultations.
BJGP Open
April 2024
University College London, Research Department for Primary Care Research and Population Health, London, UK
Background: Emotional concerns (defined as any expression of low mood, anxiety, or psychosocial stress) are an important part of the biopsychosocial care model used in modern medical practice. Previous work has demonstrated variable engagement with emotional concerns and that improved communication has been associated with reductions in emotional distress.
Aim: To examine how emotional concerns are engaged with during routine GP consultations.
Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco.
J Acquir Immune Defic Syndr
October 2023
San Francisco Department of Public Health, San Francisco, CA.
Objective: To examine trends in time spent viremic and initiation into antiretroviral treatment (ART) among persons newly diagnosed with HIV in San Francisco.
Methods: Using HIV surveillance data, we included persons diagnosed with HIV during 2012-2020, a San Francisco resident at HIV diagnosis, alive 12 months after HIV diagnosis, and had ≥2 viral load tests within 12 months after diagnosis. Percent person-time spent (pPT) >200, pPT >1500, and pPT >10,000 copies per milliliter was calculated during the 12 months after HIV diagnosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!